Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 28, 2019 - Issue 10
Submit an article Journal homepage
1,261
Views
19
CrossRef citations to date
0
Altmetric
Drug Evaluation

Enfortumab Vedotin, a fully human monoclonal antibody against Nectin 4 conjugated to monomethyl auristatin E for metastatic urothelial Carcinoma

Bradley A McGregorLank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA, USA;Department of Medicine, Harvard Medical School, Boston, MA, USAView further author information
&
Guru SonpavdeLank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA, USA;Department of Medicine, Harvard Medical School, Boston, MA, USACorrespondence[email protected]
View further author information
Pages 821-826 | Received 16 Jul 2019, Accepted 10 Sep 2019, Published online: 17 Sep 2019

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mohamad Moussa, Athanasios Papatsoris, Mohamed Abou Chakra & Athanasios Dellis. (2021) Profile of Enfortumab Vedotin in the Treatment of Urothelial Carcinoma: The Evidence to Date. Drug Design, Development and Therapy 15, pages 453-462.
Read now
Archana Upadhya, Khushwant S. Yadav & Ambikanandan Misra. (2021) Targeted drug therapy in non-small cell lung cancer: Clinical significance and possible solutions-Part I. Expert Opinion on Drug Delivery 18:1, pages 73-102.
Read now

Articles from other publishers (17)

Evgeny L. Gulyak, Vera A. Alferova, Vladimir A. Korshun & Ksenia A. Sapozhnikova. (2023) Introduction of Carbonyl Groups into Antibodies. Molecules 28:23, pages 7890.
Crossref
Heba A.S. El-Nashar, Shaden Kocaeli, Mayar Abdallah & Mohamed El-Shazly. 2023. Marine Ecosystems: A Unique Source of Valuable Bioactive Compounds. Marine Ecosystems: A Unique Source of Valuable Bioactive Compounds 355 393 .
Longkun Mao, Meihua Yang, Xinxiang Fan, Wenjie Li, Xiaodong Huang, Wang He, Tianxin Lin & Jian Huang. (2023) PD‐1/L1 inhibitors can improve but not replace chemotherapy for advanced urothelial carcinoma: A systematic review and network meta‐analysis. Cancer Innovation 2:3, pages 191-202.
Crossref
Florian Lordick, Maximilian Merz, Eva Büch & Achim Aigner. (2023) Antibody-drug conjugates as a targeted therapeutic approach across entities in oncology. Deutsches Ärzteblatt international.
Crossref
Dylan Haynes, Eric E. Morgan & Emily Y. Chu. (2023) Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings. Human Pathology.
Crossref
Surya K. De. 2023. Medicines for Cancer. Medicines for Cancer 459 488 .
Maria Letizia Calandrella, Simona Francesconi, Cecilia Caprera, Claudia Mosillo, Claudia Caserta, Diana Giannarelli, Matteo Corsi, Serena Macrini, Annalisa Guida, Stefano Ascani & Sergio Bracarda. (2022) Nectin-4 and DNA mismatch repair proteins expression in upper urinary tract urothelial carcinoma (UTUC) as a model for tumor targeting approaches: an ImGO pilot study. BMC Cancer 22:1.
Crossref
Douglas Dias e Silva, Guilherme Malandrini Andriatte & Roberto Carmagnani Pestana. (2022) Antibody-Drug Conjugates and Tissue-Agnostic Drug Development. The Cancer Journal 28:6, pages 462-468.
Crossref
Neshatul Haque, Sana Parveen, Tingting Tang, Jiaen Wei & Zunnan Huang. (2022) Marine Natural Products in Clinical Use. Marine Drugs 20:8, pages 528.
Crossref
Beverly A. Teicher & Joel Morris. (2022) Antibody-drug Conjugate Targets, Drugs, and Linkers. Current Cancer Drug Targets 22:6, pages 463-529.
Crossref
. (2022) Expert consensus on the clinical application of antibody‐drug conjugates in the treatment of malignant tumors (2021 edition). Cancer Innovation 1:1, pages 3-24.
Crossref
Paolo Tarantino, Roberto Carmagnani Pestana, Chiara Corti, Shanu Modi, Aditya Bardia, Sara M. Tolaney, Javier Cortes, Jean‐Charles Soria & Giuseppe Curigliano. (2021) Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies. CA: A Cancer Journal for Clinicians 72:2, pages 165-182.
Crossref
Keigo Iizuka, Koichiro Shoji, Tomoko Fujiyuki, Kanako Moritoh, Kei Tamura, Asuka Yoshida, Hiroki Sato, Misako Yoneda, Kazushi Asano & Chieko Kai. (2020) Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells. Research in Veterinary Science 133, pages 313-317.
Crossref
Navgeet Kaur, Anju Goyal & Rakesh K. Sindhu. (2020) Therapeutic Monoclonal Antibodies in Clinical Practice against Cancer. Anti-Cancer Agents in Medicinal Chemistry 20:16, pages 1895-1907.
Crossref
Sergey A. Dyshlovoy, Dmitry N. Pelageev, Jessica Hauschild, Yurii E. Sabutskii, Ekaterina A. Khmelevskaya, Christoph Krisp, Moritz Kaune, Simone Venz, Ksenia L. Borisova, Tobias Busenbender, Vladimir A. Denisenko, Hartmut Schlüter, Carsten Bokemeyer, Markus Graefen, Sergey G. Polonik, Victor Ph. Anufriev & Gunhild von Amsberg. (2020) Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate Cancer. Marine Drugs 18:5, pages 251.
Crossref
Hyun Jung Kim, Ho Jin Sung, Yul Min Lee, Sun Il Choi, Yun-Hee Kim, Kyun Heo & In-Hoo Kim. (2020) Therapeutic Application of Drug-Conjugated HER2 Oligobody (HER2-DOligobody). International Journal of Molecular Sciences 21:9, pages 3286.
Crossref
Danah Al Shaer, Othman Al Musaimi, Fernando Albericio & Beatriz G. de la Torre. (2020) 2019 FDA TIDES (Peptides and Oligonucleotides) Harvest. Pharmaceuticals 13:3, pages 40.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.